JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M011761200 on February 7, 2001

J. Biol. Chem., Vol. 276, Issue 18, 14867-14874, May 4, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/18/14867    most recent
M011761200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fang, X.
Right arrow Articles by Spector, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fang, X.
Right arrow Articles by Spector, A. A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pathways of Epoxyeicosatrienoic Acid Metabolism in Endothelial Cells
IMPLICATIONS FOR THE VASCULAR EFFECTS OF SOLUBLE EPOXIDE HYDROLASE INHIBITION*

Xiang FangDagger , Terry L. KaduceDagger , Neal L. Weintraub§, Shawn HarmonDagger , Lynn M. Teesch, Christophe Morisseau||, David A. Thompson||, Bruce D. Hammock||, and Arthur A. SpectorDagger §Dagger Dagger

From the Departments of Dagger  Biochemistry, § Internal Medicine, and  Molecular Analysis Facility, College of Medicine, University of Iowa, Iowa City, Iowa 52242 and the || Department of Entomology and Cancer Research Center, University of California, Davis, California 95616

Epoxyeicosatrienoic acids (EETs) are products of cytochrome P-450 epoxygenase that possess important vasodilating and anti-inflammatory properties. EETs are converted to the corresponding dihydroxyeicosatrienoic acid (DHET) by soluble epoxide hydrolase (sEH) in mammalian tissues, and inhibition of sEH has been proposed as a novel approach for the treatment of hypertension. We observed that sEH is present in porcine coronary endothelial cells (PCEC), and we found that low concentrations of N,N'-dicyclohexylurea (DCU), a selective sEH inhibitor, have profound effects on EET metabolism in PCEC cultures. Treatment with 3 µM DCU reduced cellular conversion of 14,15-EET to 14,15-DHET by 3-fold after 4 h of incubation, with a concomitant increase in the formation of the novel beta -oxidation products 10,11-epoxy-16:2 and 8,9-epoxy-14:1. DCU also markedly enhanced the incorporation of 14,15-EET and its metabolites into PCEC lipids. The most abundant product in DCU-treated cells was 16,17-epoxy-22:3, the elongation product of 14,15-EET. Another novel metabolite, 14,15-epoxy-20:2, was present in DCU-treated cells. DCU also caused a 4-fold increase in release of 14,15-EET when the cells were stimulated with a calcium ionophore. Furthermore, DCU decreased the conversion of [3H]11,12-EET to 11,12-DHET, increased 11,12-EET retention in PCEC lipids, and produced an accumulation of the partial beta -oxidation product 7,8-epoxy-16:2 in the medium. These findings suggest that in addition to being metabolized by sEH, EETs are substrates for beta -oxidation and chain elongation in endothelial cells and that there is considerable interaction among the three pathways. The modulation of EET metabolism by DCU provides novel insight into the mechanisms by which pharmacological or molecular inhibition of sEH effectively treats hypertension.

* This study was supported by National Institutes of Health Program Project Grants HL49264 and HL62984 (to A. A. S. and N. L. W.), by an American Heart Association Heartland Affiliate Beginning Grant-in-aid 0060413Z (to X. F.), by an American Heart Association Clinician-Scientist Award 96004540 (to N. L. W.), by NIEHS Grant R01 ES02710, the NIEHS Superfund Basic Research Program P42 ES04699, and NIEHS Center P30 ES05707 (to B. D. H.) from the National Institutes of Health, and by National Institutes of Health Training Grant HL07013 (to D. A. T.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Dagger To whom correspondence should be addressed: Dept. of Biochemistry, 4-403 BSB, University of Iowa, Iowa City, IA 52242. Tel.: 319-335-7913; Fax: 319-335-9570; E-mail: arthur-spector@uiowa.edu.

Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Respir. Cell Mol. Bio.Home page
C. Morin, M. Sirois, V. Echave, M. M. Gomes, and E. Rousseau
EET Displays Anti-Inflammatory Effects in TNF-{alpha} Stimulated Human Bronchi: Putative Role of CPI-17
Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 192 - 201.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. J. Corenblum, V. E. Wise, K. Georgi, B. D. Hammock, P. A. Doris, and M. Fornage
Altered Soluble Epoxide Hydrolase Gene Expression and Function and Vascular Disease Risk in the Stroke-Prone Spontaneously Hypertensive Rat
Hypertension, February 1, 2008; 51(2): 567 - 573.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. Hamanaka, M.-Y. Jian, D. S. Weber, D. F. Alvarez, M. I. Townsley, A. B. Al-Mehdi, J. A. King, W. Liedtke, and J. C. Parker
TRPV4 initiates the acute calcium-dependent permeability increase during ventilator-induced lung injury in isolated mouse lungs
Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L923 - L932.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
V. Y. Ng, Y. Huang, L. M. Reddy, J. R. Falck, E. T. Lin, and D. L. Kroetz
Cytochrome P450 Eicosanoids are Activators of Peroxisome Proliferator-Activated Receptor {alpha}
Drug Metab. Dispos., July 1, 2007; 35(7): 1126 - 1134.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
A. A. Spector and A. W. Norris
Action of epoxyeicosatrienoic acids on cellular function
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
W. B. Campbell and J. R. Falck
Arachidonic Acid Metabolites as Endothelium-Derived Hyperpolarizing Factors
Hypertension, March 1, 2007; 49(3): 590 - 596.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X. Fang, F. M. Faraci, T. L. Kaduce, S. Harmon, M. L. Modrick, S. Hu, S. A. Moore, J. R. Falck, N. L. Weintraub, and A. A. Spector
20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: role of cyclooxygenase
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2301 - H2307.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
J. M. Seubert, C. J. Sinal, J. Graves, L. M. DeGraff, J. A. Bradbury, C. R. Lee, K. Goralski, M. A. Carey, A. Luria, J. W. Newman, et al.
Role of Soluble Epoxide Hydrolase in Postischemic Recovery of Heart Contractile Function
Circ. Res., August 18, 2006; 99(4): 442 - 450.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
B. B. Davis, C. Morisseau, J. W. Newman, T. L. Pedersen, B. D. Hammock, and R. H. Weiss
Attenuation of Vascular Smooth Muscle Cell Proliferation by 1-Cyclohexyl-3-dodecyl Urea Is Independent of Soluble Epoxide Hydrolase Inhibition
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 815 - 821.
[Abstract] [Full Text] [PDF]

Home page
 Protein Sci.Home page
G. A. Gomez, C. Morisseau, B. D. Hammock, and D. W. Christianson
Human soluble epoxide hydrolase: Structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids
Protein Sci., January 1, 2006; 15(1): 58 - 64.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X. Fang, S. Hu, B. Xu, G. D. Snyder, S. Harmon, J. Yao, Y. Liu, B. Sangras, J. R. Falck, N. L. Weintraub, et al.
14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-{alpha}
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H55 - H63.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Liu, Y. Zhang, K. Schmelzer, T.-S. Lee, X. Fang, Y. Zhu, A. A. Spector, S. Gill, C. Morisseau, B. D. Hammock, et al.
The antiinflammatory effect of laminar flow: The role of PPAR{gamma}, epoxyeicosatrienoic acids, and soluble epoxide hydrolase
PNAS, November 15, 2005; 102(46): 16747 - 16752.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
X. Fang, S. Hu, T. Watanabe, N. L. Weintraub, G. D. Snyder, J. Yao, Y. Liu, J. Y.-J. Shyy, B. D. Hammock, and A. A. Spector
Activation of Peroxisome Proliferator-Activated Receptor {alpha} by Substituted Urea-Derived Soluble Epoxide Hydrolase Inhibitors
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 260 - 270.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
O. Jung, R. P. Brandes, I.-H. Kim, F. Schweda, R. Schmidt, B. D. Hammock, R. Busse, and I. Fleming
Soluble Epoxide Hydrolase Is a Main Effector of Angiotensin II-Induced Hypertension
Hypertension, April 1, 2005; 45(4): 759 - 765.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. R. Smith, K. E. Pinkerton, T. Watanabe, T. L. Pedersen, S. J. Ma, and B. D. Hammock
Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor
PNAS, February 8, 2005; 102(6): 2186 - 2191.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X. Fang, N. L. Weintraub, R. B. McCaw, S. Hu, S. D. Harmon, J. B. Rice, B. D. Hammock, and A. A. Spector
Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2412 - H2420.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
V. Le Quere, E. Plee-Gautier, P. Potin, S. Madec, and J.-P. Salaun
Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides
J. Lipid Res., August 1, 2004; 45(8): 1446 - 1458.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
Z. Yu, B. B. Davis, C. Morisseau, B. D. Hammock, J. L. Olson, D. L. Kroetz, and R. H. Weiss
Vascular localization of soluble epoxide hydrolase in the human kidney
Am J Physiol Renal Physiol, April 1, 2004; 286(4): F720 - F726.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. S. Chuang, C. Helvig, M. Taimi, H. A. Ramshaw, A. H. Collop, M.'a. Amad, J. A. White, M. Petkovich, G. Jones, and B. Korczak
CYP2U1, a Novel Human Thymus- and Brain-specific Cytochrome P450, Catalyzes {omega}- and ({omega}-1)-Hydroxylation of Fatty Acids
J. Biol. Chem., February 20, 2004; 279(8): 6305 - 6314.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. F. Alvarez, E.-A. B. Gjerde, and M. I. Townsley
Role of EETs in regulation of endothelial permeability in rat lung
Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L445 - L451.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Fornage, E. Boerwinkle, P. A. Doris, D. Jacobs, K. Liu, and N. D. Wong
Polymorphism of the Soluble Epoxide Hydrolase Is Associated With Coronary Artery Calcification in African-American Subjects: The Coronary Artery Risk Development In Young Adults (CARDIA) Study
Circulation, January 27, 2004; 109(3): 335 - 339.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. L. Kaduce, X. Fang, S. D. Harmon, C. L. Oltman, K. C. Dellsperger, L. M. Teesch, V. R. Gopal, J. R. Falck, W. B. Campbell, N. L. Weintraub, et al.
20-Hydroxyeicosatetraenoic Acid (20-HETE) Metabolism in Coronary Endothelial Cells
J. Biol. Chem., January 23, 2004; 279(4): 2648 - 2656.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H. Wang, L. Lin, J. Jiang, Y. Wang, Z. Y. Lu, J. A. Bradbury, F. B. Lih, D. W. Wang, and D. C. Zeldin
Up-Regulation of Endothelial Nitric-Oxide Synthase by Endothelium-Derived Hyperpolarizing Factor Involves Mitogen-Activated Protein Kinase and Protein Kinase C Signaling Pathways
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 753 - 764.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
T. Watanabe, C. Morisseau, J. W. Newman, and B. D. Hammock
IN VITRO METABOLISM OF THE MAMMALIAN SOLUBLE EPOXIDE HYDROLASE INHIBITOR, 1-CYCLOHEXYL-3-DODECYL-UREA
Drug Metab. Dispos., July 1, 2003; 31(7): 846 - 853.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Cronin, S. Mowbray, H. Durk, S. Homburg, I. Fleming, B. Fisslthaler, F. Oesch, and M. Arand
The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase
PNAS, February 18, 2003; 100(4): 1552 - 1557.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X. Fang, N. L. Weintraub, C. L. Oltman, L. L. Stoll, T. L. Kaduce, S. Harmon, K. C. Dellsperger, C. Morisseau, B. D. Hammock, and A. A. Spector
Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide
Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2306 - H2314.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
T. Lu, M. VanRollins, and H.-C. Lee
Stereospecific Activation of Cardiac ATP-Sensitive K+ Channels by Epoxyeicosatrienoic Acids: A Structural Determinant Study
Mol. Pharmacol., November 1, 2002; 62(5): 1076 - 1083.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. A. Cowart, S. Wei, M.-H. Hsu, E. F. Johnson, M. U. Krishna, J. R. Falck, and J. H. Capdevila
The CYP4A Isoforms Hydroxylate Epoxyeicosatrienoic Acids to Form High Affinity Peroxisome Proliferator-activated Receptor Ligands
J. Biol. Chem., September 13, 2002; 277(38): 35105 - 35112.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. B. Davis, D. A. Thompson, L. L. Howard, C. Morisseau, B. D. Hammock, and R. H. Weiss
Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation
PNAS, February 6, 2002; (2002) 261710799.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. D. Imig, X. Zhao, J. H. Capdevila, C. Morisseau, and B. D. Hammock
Soluble Epoxide Hydrolase Inhibition Lowers Arterial Blood Pressure in Angiotensin II Hypertension
Hypertension, February 1, 2002; 39(2): 690 - 694.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
R. J. Roman
P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
Physiol Rev, January 1, 2002; 82(1): 131 - 185.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
B. Yang, L. Graham, S. Dikalov, R. P. Mason, J. R. Falck, J. K. Liao, and D. C. Zeldin
Overexpression of Cytochrome P450 CYP2J2 Protects against Hypoxia-Reoxygenation Injury in Cultured Bovine Aortic Endothelial Cells
Mol. Pharmacol., August 1, 2001; 60(2): 310 - 320.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. C. Zeldin
Epoxygenase Pathways of Arachidonic Acid Metabolism
J. Biol. Chem., September 21, 2001; 276(39): 36059 - 36062.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. B. Davis, D. A. Thompson, L. L. Howard, C. Morisseau, B. D. Hammock, and R. H. Weiss
Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation
PNAS, February 19, 2002; 99(4): 2222 - 2227.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
W. B. Campbell, C. Deeter, K. M. Gauthier, R. H. Ingraham, J. R. Falck, and P.-L. Li
14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of KCa channels
Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1656 - H1664.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.